Bipartisan bill to streamline U.S. response to foreign theft of IP may hasten clarity on biotech impact

As the biopharma industry awaits guidance from the government on the scope and potential impact of proposed technology export controls, a new congressional bill could help speed the process. Members of the Senate Select Committee on Intelligence introduced a bipartisan bill Friday that seeks to create a federal office to coordinate security policy aimed at combating the threat of technology theft by China and other foreign governments.

The proposed Office of Critical Technologies and Security would lead the interagency process to identify "emerging and foundational technologies" that will be subject to export controls by the U.S. Department of Commerce under the Export Control Reform Act of 2018...